Sort
48,018 grants matching “immunotherapy”
Project 2: Integrating race, ethnicity, and genomic ancestry across GENIE to understand genetic and environmental contributions to pan-cancer risk, prognosis, and outcomes
$427,115Jian Zhang · Sloan-Kettering Inst Can Research · P01 · FY2025 · CA
Achieving Therapeutic Antigent-Specific Tolerance in Type 1 Diabetes
$427,109Matthias G. Von Herrath · La Jolla Institute For Immunology · U01 · FY2007 · DK
Microphysiological platform for analyzing multiple myeloma's tumor microenvironment, enabling immunotherapy assessment and drug screening.
$427,095Tania Tali Konry · Northeastern University · R33 · FY2024 · CA
Biomedical Studies and Cellular Imaging via Atomic Force Microscopy
$427,054Albert J Jin · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2024 · EB
Growth Regulation Section
$427,052Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Development of Immunologic therapies against uveitis
$427,033Charles E Egwuagu · National Eye Institute · ZIA · FY2020 · EY
Early change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancer
$427,031Cloud Peter Paweletz · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.
$427,021David Porter · University Of Pennsylvania · P01 · FY2019 · CA
Dermal Lymphatic Transport and Cutaneous Immune Balance
$427,003Amanda W. Lund · New York University School Of Medicine · R01 · FY2024 · AR
Antigenic determinants of asthma-associated allergens for design of immunotherapy
$426,963Anna Pomes · Indoor Biotechnologies · R01 · FY2010 · AI
Targeting exosomal PDL1 to improve immunotherapy
$426,960Wei Guo · Wistar Institute · P50 · FY2024 · CA
Project 4: Using Synthetic Immunology to Improve Activity and Specificity, and Overcome Resistance, in Cellular Therapy
$426,943David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA
Project 4: Using Synthetic Immunology to Improve Activity and Specificity, and Overcome Resistance, in Cellular Therapy
$426,943David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2020 · CA
Project 4: Using Synthetic Immunology to Improve Activity and Specificity, and Overcome Resistance, in Cellular Therapy
$426,943David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2023 · CA
Establishment of immunocompetent spontaneous glioma model to study glioma-associated astrocytes
$426,938Tomasz K Kordula · Virginia Commonwealth University · R21 · FY2021 · NS
HIFU-enhanced tumor vaccines
$426,891Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2010 · EB
Establishing a Hub to Support Education of Biomanufacturing Technicians in Cell Therapy and Immunotherapy
$426,886Orlando R De Lange · Shoreline Community College · · FY2021 · EDU
Microenvironmental Influences in Cancer
$426,752Jin Chen · Vanderbilt University · T32 · FY2019 · CA
CLINICAL IMAGING AND RADIATION DOSIMETRY
$426,741James R Bading · Beckman Research Institute/City Of Hope · P01 · FY2010 · CA
Synthetic Studies Related to Cancer Research/Treatment
$426,570Paul Wender · Stanford University · R01 · FY2020 · CA
TOLERANCE INDUCTION IN PANCREATIC ISLET TRANSPLANTATION
$426,451University Of Illinois At Chicago · R01 · FY2001 · DK
Project 4: Using Synthetic Immunology to Improve Activity and Specificity, and Overcome Resistance, in Cellular Therapy
$426,439David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2021 · CA
CROSSTALK BETWEEN GUT MICROBIOTA AND HEPATOCELLULAR CARCINOMA INDUCED BY METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
$426,425Prasun Kumar Jalal · Baylor College Of Medicine · R21 · FY2024 · CA
Core 2
$426,419Kavita Dhodapkar · Emory University · P01 · FY2022 · CA
Immune Regulation of Lung Squamous Metastasis
$426,393Chad V Pecot · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA